Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Encouraged by this potential non-Covid angle >
https://www.globenewswire.com/news-release/2023/09/04/2736780/0/en/Transdermal-Medical-Patch-Market-worth-10-79-Billion-by-2028-Exclusive-Report-by-The-Insight-Partners.html#:~:text=Transdermal%20Medical%20Patch%20Market%20in,published%20by%20The%20Insight%20Partners.
From the article above:
“In February 2023, Revive Therapeutics Ltd. entered into a research collaboration agreement with PharmaTher Holdings Ltd. to evaluate the delivery of 3,4-Methylenedioxymethamphetamine ("MDMA") using PharmaTher's novel microneedle patch ("MN-Patch") delivery technology. The MDMA MN-Patch enables flexible drug load capacity and combinations, controlled released delivery, and the ability to present desired pharmacokinetic and safety profiles, overcoming the potential obstacles of oral dosing.”
Lockdown is around the corner. We have elections and they need to manipulate our votes. Too bad we can't get some crumbs to make the stock go to $5. Only the big pharma is going to get the cash. This is BS.
Unfortunately it is world wide.
I spoke to a friend in Australia 4 days ago. Covid is running rampant there.
Boston is getting slammed as over 200,000 people are back for school
from every point on the globe.
Next lol Gio... see any news about this ? I wonder why they dont want people to know? Maybe summer Flu lol. But now management say bucy no good for covid why ran out of money and trying to get funding for whatever..... I am liking my new investment to tell you the truth the New people added to the business:)
“I got the US Open bug”
— Dana Parish (@danaparish) September 2, 2023
US Open players struggle to understand just what the heck is making them all so damn sick!
HINT: it’s not flu season https://t.co/ui53HaK9Lt
Wouldn't surprise me Lol....anyone look at Bdpt stock? Ceo etc. Not even taking salary. If people here can't see the Dd there ohhhhh well....lol delete this don't give a fck Bmt is right about rhe
Company when investors realize lol..... longs know me Here sorry byr Wake the fck up need to get rid of the dumb ass Mf lol
A little defensive ‘eh stereo?
I heard MF is working on a ED drug.lol might rise the stock.
What you claim to be ""bullying"", to me is simply shining a light on rank nonsense!
I do understand why ye would be peeved however........woke twats such as yourself never like being called out for yer bullshite.
So is the phrase “know it all”.
Bullied, is a way overused term when you don't agree with someone else's opinion
Good point. My problem is when I think of pumpers I think of Hotmeat. LOL. He was beyond bully. In fact I'm sure there's a word for him. I really shouldn't give the impression that all pumpers are bullies.
LOL @ "bullied". Aw..sweetheart.. Flawed posters like you festering on a board spewing non-stop negativity (without quantifying / backing it up) are treated as deserved from what I have observed. Regardless of this stock, you have a great deal of changing to do fella or Ms. Design yourself a better life charter for gods sake.
Both sides of the trade have been represented here for a while, some legit and some calculated. This is penny stocks and that's what happens, as we all know. We all trade and some of us may be gambling on dead wind, a collapse of the stock. I'm trading the other side.
The pumpers have bullied people on this board for 3 years now. They're time is up and some can't handle it. They were totally wrong about this company and cannot face the music. They're weak and it shows.
Fair enough. Then why are you tolerant of the pumpers who think they “know it all”. Come on dude your behavior of giving them a free pass does not fit your explanation at all. Maybe some honesty and consistency are in order. Give it a try.
Is pumping a share price for profit ethical and credible?
You may be correct with your assumption however, I do know that most penny stocks fail, in fact the great majority lose money yearly. I'm not an expert but I've been trading penny stocks for quite some time and have only made money with a handful. It's a crap shoot, all you can do is do your due diligence and hope for the best since none of us really know the inner workings of the company. I'm very close to retirement so I have to be careful with my money but I keep aside some to play with...What I can't stand is a no it all like Benson, thinking he has it all figured out. No one does, even day traders who trade penny stocks fast and furious daily!
No one knows what’s happening in with the company because the ceo is one of the worst to ever head a public corporation. Every pr is a maze trying a decipher what he is saying. You think he doesn’t look like a complete idiot for now pivoting to bio weapons? He doesn’t have a clue how to run a company. He was handed billions on a silver platter with Covid but still screwed it up.
Fair enough. So is pumping a share price for profit ethical and credible? Perhaps this is an opportunity for personal growth by overcoming the fear of answering the question. You have a lot to gain here by answering my friend.
Show us the trial that proves it is better than placebo.
$RVVTF reformulated drug will work on all variants of #covid Reducing symptoms and keeping you out of hospital.
I’m not bashing the stock anymore than you are pumping the stock. Get a clue rookie.
I'm not pumping the stock, just want you to stop degrading it without any direct knowledge of what is going on in the company. You claim to know what is going on inside the company which is bullshit.
While several come here to "babble" all day, ""some"" of us trade this stock for easy profits that add up over time.
No wonder idiots like you never make any $$......youre too busy posting irrelevant bullshite on free msg boards.
#circusclowns
Repetitive Bullshite
What is your reasoning for pumping this stock? I'll ask you the same question I asked Egomike. Is pumping a share price for profit ethical and credible? He still hasn't answered the question.
In case you haven’t noticed this stock has crashed to almost zero and it’s just about broke and bankrupt. It’s your problem that you mistake the truth for negativity. Hear no evil, speak no evil, see no evil. Is that your mantra?
I've never met him, but based on the companies results so far, it's hard to like his leadership.
I don't like the CEO.
What is your reasoning behind bashing this stock? Is there an ulterior motive? I just don't understand why investors comment negatively, it makes no sense to me. Negative comments, if anyone reads them, only creates hesitation from those who would actually believe them....The only reasonable explanation is that you want the stock to go down...or your ego is so big that you just have to be right?
R/S is the next chess move.
Weak again Egomike. Come on dude is that all you got?
The latest strategy might actually have some teeth to it!
As in Waterloo, Iowa?
Looks like JoeBBears and shorts have a serious case of indigestion with RVVTF up 38% today
Stoke BS fear into the population, let the stock soar and get me outta here!
Reformulated Covid drug. #CovidIsNotOver $RVVTF
Americans at high risk advised to wear masks as new Covid variant detected | Coronavirus | The Guardian
https://www.theguardian.com/world/2023/aug/24/new-covid-variant-masking-high-risk-people
Ye asked how will it be funded and I responded as such so im not sure what the point of this gibberish filled response is.
I not once chimed in on whether it would be successful or not.
Focus jester.........................
How many times did he use “potential” in the last PR.
Market read it like. They see the pump as sell the news. Dropping like a rock in water
What a scam
A few more vague word salad PR’s can get him to the holidays. Happy New Years Mike
Key wording “seek to”. Not “has” or “is”. Hell anyone can say they “seek to” win the lottery
Yeah that’s his MO. Let’s see how long he can drag out bucillamine 2.0. The shareholders are giving him $30,000 bucks a month while he plays golf. Stringing investors along fits his lifestyle just fine. Why change now?
The Company will seek to initiate research studies in line with the Company’s commitment to advancing the clinical and commercial development of Bucillamine through the following strategic initiatives:
Target Indications: Novel Bucillamine in an injectable version to expand on its potential therapeutic utility targeting rare disorders such as ischemia-reperfusion injury (i.e. organ transplantation), acute respiratory distress syndrome, and potential medical countermeasures, that may come with regulatory incentives awarded by the FDA, such as emergency use authorization, orphan drug, fast track, and breakthrough therapy designations.
Pharmaceutical Partnerships: Work with interested pharmaceutical partners to pursue potential domestic and international regulatory approvals and new clinical studies for infectious, inflammatory and respiratory disorders.
Government Support: Seek out potential funding and evaluation opportunities offered by, but not limited to, the Defence Research and Development Canada (DRDC) and the Biomedical Advanced Research and Development Authority (BARDA), the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS).
At this time, the Company will only provide regular updates via press releases as information becomes available.
He can’t. He’s just trying to keep this going till he can bail or has to close up shop
Upon completion of the formulation development, which is expected by end-2023, the Company will seek to initiate research studies in line with the Company’s commitment to advancing the clinical and commercial development of Bucillamine through the following strategic initiatives:
Target Indications: Novel Bucillamine in an injectable version to expand on its potential therapeutic utility targeting rare disorders such as ischemia-reperfusion injury (i.e. organ transplantation), acute respiratory distress syndrome, and potential medical countermeasures, that may come with regulatory incentives awarded by the FDA, such as emergency use authorization, orphan drug, fast track, and breakthrough therapy designations.
Pharmaceutical Partnerships: Work with interested pharmaceutical partners to pursue potential domestic and international regulatory approvals and new clinical studies for infectious, inflammatory and respiratory disorders.
Government Support: Seek out potential funding and evaluation opportunities offered by, but not limited to, the Defence Research and Development Canada (DRDC) and the Biomedical Advanced Research and Development Authority (BARDA), the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS).
Followers
|
339
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
36630
|
Created
|
02/23/17
|
Type
|
Free
|
Moderators Classic Warrior |
Scientific Rationale of Bucillamine
Preclinical and clinical studies have demonstrated that reactive oxygen species contribute to the destruction and programmed cell death of pulmonary epithelial cells.1 N-acetyl-cysteine (NAC) has been shown to significantly attenuate clinical symptoms in respiratory viral infections in animals and humans, primarily via donation of thiols to restore antioxidant and to reduce the activity of cellular glutathione 2,3,4,5. Bucillamine (N-(mercapto-2-methylpropionyl)-l-cysteine) has a well-known safety profile and is prescribed in the treatment of rheumatoid arthritis in Japan and South Korea for over 30 years. Bucillamine, a cysteine derivative with two thiol groups, has been shown to be 16 times more potent as a thiol donor in vivo than NAC 6. The drug is non-toxic with high cellular permeability. The basis of the clinical study will analyze if Bucillamine has the potential, via restoration of glutathione activity and other anti-inflammatory activity, to lessen the negative consequences of SARS-CoV2 infection in the lungs.
| Psilocin Pharma Corp. has developed production solutions for the active compound Psilocybin. Our process encompassed with our intellectual property cover methods of production of Psilocybin based formulations. Psilocin Pharma Corp’s range of products have been engineered to work synergistically with the body's own natural pathways of absorption while offering a contemporary approach to consumption. Psilocin Pharma also has strong relationships with specific lab partners in certain areas like Brazil, where these formulations are legally approved and plan to sell products in these jurisdictions. | |
| |
Mental Health (Depression, PTSD & Anxiety)
|
Supplements for Brain Health & Cognitive Enhancement
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |